Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Nov;41(11):2430-7.
doi: 10.1016/j.jcrs.2015.05.026.

Incidence of rhegmatogenous retinal detachment after bag-in-the-lens intraocular lens implantation

Marie-José Tassignon  1 , Jonas J I Van den Heurck  1 , Kim B M Boven  1 , Jan Van Looveren  1 , Kristien Wouters  1 , Ernesto Bali  1 , Sorcha Ní Dhubhghaill  1 , Danny G P Mathysen  2
Affiliations

Incidence of rhegmatogenous retinal detachment after bag-in-the-lens intraocular lens implantation

Marie-José Tassignon et al. J Cataract Refract Surg. 2015 Nov.

Abstract

Purpose: To determine the incidence of rhegmatogenous retinal detachment (RRD) and associated risk factors after phacoemulsification and bag-in-the-lens intraocular lens (IOL) implantation.

Setting: Antwerp University Hospital, Department of Ophthalmology, Antwerp, Belgium.

Design: Prospective cohort study.

Methods: All consecutive bag-in-the-lens IOL implantations performed between January 2001 and December 2007 were included, with the exception of combined procedures and IOL exchanges. The retinal detachment (RD) incidence was studied in the total cohort, in a subgroup of patients with 1 to 5 years of follow-up, and finally in the group remaining after exclusion of all risk factors except gender.

Results: RD after bag-in-the-lens IOL implantation in 1323 eyes with an average follow-up of 44.75 months (range 0 to 152 months) was found in 19 eyes (1.44%). The 1-year RD incidence was 0.49% (5 RD cases in 1024 eyes) (0.00% in patients without risk factors). The 2-year cumulative RD incidence was 0.84% (9 RD cases in 931 eyes; 0.15% without risk factors). Four clinically significant risk factors were confirmed: male gender, young age at time of surgery (<60 years), axial myopia (axial length ≥25 mm), and history of contralateral RD in the total cohort.

Conclusion: The RRD incidence following bag-in-the-lens IOL implantation was comparable to that seen after lens-in-the-bag (LIB) implantation. The wide variation in study design in the literature precludes direct comparison, so there is a need for standardization in evaluating RRD incidence after cataract surgery. Future prospective studies should consider patients with and without risk factors (except gender) separately.

Financial disclosure: Prof. dr. M.J. Tassignon has intellectual property rights to the bag-in-the-lens intraocular lens (U.S. patent 6 027 531; EU patent 009406794; PCT/120268), which is licensed to Morcher GmbH, Stuttgart, Germany.

PubMed Disclaimer

MeSH terms